Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2011
12/07/2011CN102267978A 作为激酶活性调节剂的1,3-二芳基取代的脲 As the kinase activity of 1,3-diaryl-substituted urea modifier
12/07/2011CN102267948A 芴并二咪唑衍生物及其制备方法 Fluorene and two imidazole derivatives and its preparation method
12/07/2011CN101501008B 芳基哌嗪衍生物及其用途 Aryl piperazine derivatives and their use
12/07/2011CN101389610B 作为香草素受体1(vr1)抑制剂的新苯并咪唑衍生物 As vanilloid receptor 1 (vr1) inhibitors new benzimidazole derivatives
12/07/2011CN101300235B 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 As p2x3 and diamino pyrimidine derivatives p2x2 / 3 modifier
12/07/2011CN101253159B 作为P2X<sub>3</sub>和P2X<sub>2/3</sub>调节剂的二氨基嘧啶类化合物 As P2X <sub> 3 </ sub> and diaminopyrimidines P2X <sub> 2/3 </ sub> modifier compounds
12/06/2011US8071975 Electronic devices made with electron transport and/or anti-quenching layers
12/06/2011US8071796 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
12/06/2011US8071782 Synthesis of 1,3,4-trisubstituted and 1,3,4,5-tetrasubstituted pyrazoles
12/06/2011US8071781 Process for preparing rabeprazole sodium
12/06/2011US8071771 Bicyclic spirohydantoin CGRP receptor antagonists
12/06/2011US8071770 Spirohydantoin aryl CGRP receptor antagonists
12/06/2011US8071768 Alkylquinoline and alkylquinazoline kinase modulators
12/06/2011US8071762 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
12/06/2011US8071635 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/06/2011US8071629 2-pyridinylcycloalkylcarboxamide derivatives as fungicides
12/06/2011US8071627 2-pyridinylethylcarboxamide derivatives and their use as fungicides
12/06/2011US8071626 Chelating agents and highly luminescent and stable chelates and their use
12/06/2011US8071618 Caspase inhibitors and uses thereof
12/06/2011US8071617 Modulators of cellular adhesion
12/06/2011US8071616 Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
12/06/2011US8071615 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/06/2011US8071612 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
12/06/2011US8071611 Spirocyclic heterocyclic derivatives and methods of their use
12/06/2011US8071602 Piperidine and piperazine derivatives
12/06/2011US8071601 Aminoquinoline derivatives and their use as adenosine A3 ligands
12/06/2011US8071586 Heterocyclyl compounds
12/06/2011CA2628844C Pyrazole derivatives and their medical use
12/06/2011CA2626085C S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
12/06/2011CA2600570C Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
12/06/2011CA2584666C Pyrimidine derivative condensed with a non-aromatic ring
12/06/2011CA2582029C Aryl nitrogen-containing bicyclic compounds and methods of use
12/06/2011CA2537054C 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester-methanesulphonate and use thereof as a medicament
12/06/2011CA2536642C Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives
12/06/2011CA2536637C 5-substituted-alkylaminopyrazole derivatives and their use as pesticides
12/06/2011CA2504160C Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
12/06/2011CA2501542C Method for the synthesis of a benzimidazole compound
12/06/2011CA2485430C Process for the preparation of a hydrate of an anthranilic acid derivative
12/06/2011CA2485351C Cyanoguanidine prodrugs
12/06/2011CA2483662C Heterocyclic derivatives as opioid receptor modulators
12/05/2011CA2802290A1 Novel microbiocidal dioxime ether derivatives
12/01/2011WO2011150198A1 Azolyl urea compounds and methods of use thereof
12/01/2011WO2011150183A1 Radiolabeled compounds and methods thereof
12/01/2011WO2011150156A2 Heteroaryl compounds and methods of use thereof
12/01/2011WO2011149012A1 Prophylactic or therapeutic agent for retinal/choroidal denaturation diseases comprising isoquinolinesulfonyl derivative as active ingredient, prophylactic or therapeutic method for retinal/choroidal denaturation diseases, and isoquinolinesulfonyl derivative or pharmaceutically acceptable salt thereof and use thereof
12/01/2011WO2011149011A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof
12/01/2011WO2011149010A1 Novel indazole derivative or salt thereof, intermediate for the production of same, prophylactic or therapeutic agent for chorioretinal denaturative diseases and therapeutic method for chorioretinal denaturative diseases each utilizing same, and use of indazole derivative or salt thereof
12/01/2011WO2011148956A1 Fused imidazole derivative
12/01/2011WO2011148922A1 Novel quinazoline compound
12/01/2011WO2011148888A1 Heterocyclic ring compound and h1 receptor antagonist
12/01/2011WO2011148208A1 8-hydroxy-quinoline derivatives
12/01/2011WO2011147951A1 Cycloamino derivatives as gpr119 antagonists
12/01/2011WO2011147910A1 Pyrazole compounds as sigma receptor inhibitors
12/01/2011WO2011147780A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
12/01/2011WO2011147765A1 Pyridinylcarboxylic acid derivatives as fungicides
12/01/2011WO2011147102A1 Synthetic method for 6,7-substituents-4-aniline quinazoline
12/01/2011WO2011094260A3 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
12/01/2011WO2011093524A9 Di - substituted pyridine derivatives as anticancers
12/01/2011US20110295016 A new process for preparing 4-[4-methyl-5-(cl-10alkylthio/c5-10aryl-cl-6alkylthio)-4h-1,2,4-triazol-3-yl]pyridines
12/01/2011US20110295013 Process for preparing 1-(4-piperidinyl)benzimidazolone derivatives
12/01/2011US20110295007 Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
12/01/2011US20110295000 Production method
12/01/2011US20110294854 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS
12/01/2011US20110294853 Bis Aromatic Compounds for Use in the Treatment of Inflammation
12/01/2011US20110294850 Indoline derivatives
12/01/2011US20110294848 Small molecule inhibitors of botulinum neurotoxins
12/01/2011US20110294846 Indole derivatives as anticancer agents
12/01/2011US20110294840 Hydrazide compound and use of the same in pest control
12/01/2011US20110294836 Aryl gpr119 agonists and uses thereof
12/01/2011US20110294820 N-Oxides of n-Phenyl-2-pyrimidine-amine Derivatives
12/01/2011US20110294819 Hepatitis C Virus Inhibitors
12/01/2011US20110294818 1h-quinazoline-2,4-diones
12/01/2011US20110294817 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine d3 receptor
12/01/2011US20110294812 P38 map kinase inhibitors
12/01/2011US20110294810 Substituted (pyridyl)-azinylamine derivatives as plant protection agents
12/01/2011US20110294809 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
12/01/2011US20110294808 Indazole Compounds As CCR1 Receptor Antagonists
12/01/2011US20110294807 Compounds for the prevention and treatment of cardiovascular disease
12/01/2011US20110294804 Novel bicyclic heterocyclic compound
12/01/2011US20110294796 Benzotriazine inhibitors of kinases
12/01/2011US20110294793 Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors
12/01/2011US20110294789 Compounds for rho kinase inhibition and for improving learning and memory
12/01/2011US20110294788 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
12/01/2011US20110294780 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
12/01/2011US20110294777 Beta-lactamase inhibitors
12/01/2011US20110294775 Novel compounds
12/01/2011US20110294761 Stem cell cultures
12/01/2011US20110294749 Diaminopyrimidinecarboxamide derivative
12/01/2011US20110293719 Novel compounds and compositions and methods of use
12/01/2011US20110291081 Material for organic electroluminescence device and organic electroluminescence device using the same
12/01/2011CA2800724A1 Novel indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof
12/01/2011CA2800618A1 Heteroaryl compounds and methods of use thereof
12/01/2011CA2800530A1 Inhibitors of hcv ns5a
12/01/2011CA2800521A1 Fused imidazole derivative
12/01/2011CA2800509A1 Inhibitors of hcv ns5a
12/01/2011CA2800384A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
12/01/2011CA2800103A1 Pyrazole compounds as sigma receptor inhibitors
12/01/2011CA2798419A1 8-hydroxy-quinoline derivatives
11/2011
11/30/2011EP2390250A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/30/2011EP2390248A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies